C. Debruyne

Prognostic Factors for Survival in Adult Patients With Cerebral Low-Grade Glioma

Francesco Pignatti, Martin J. van den Bent, Desmond Curran et al. · Journal of Clinical Oncology · 2002 · 948 citations

Medicine, Oncology, Surgery +17

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer

Jan P. van Meerbeeck, G. Kramer, Paul Van Schil et al. · JNCI Journal of the National Cancer Institute · 2007 · 710 citations · Full text

Medicine, Oncology, Surgery +13

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

Jan P. van Meerbeeck, Rabab Gaafar, Christian Manegold et al. · Journal of Clinical Oncology · 2005 · 621 citations · Full text

Medicine, Oncology, Pharmacology +14

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa et al. · The Lancet Oncology · 2016 · 497 citations · Full text

Medicine, Immunology, Oncology +16

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

Egbert F. Smit, J.P.A.M van Meerbeeck, P. Lianes et al. · Journal of Clinical Oncology · 2003 · 352 citations

Medicine, Oncology, Pharmacology +13